Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07719270Not yet recruiting
Randomised, open-label trial of triamcinolone acetonide in trismus, edema and pain (3 arms), sponsored by Allama Iqbal Medical College. Primary endpoint: Postoperative Pain Severity at 7 days. Planned start Jan 2027; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07719270.